-
Dog likely source of deadly pneumonic plague in China
The city of Ziketan has been sealed off sine the weekend after an outbreak of pneumonic plague; the first fatality was a 32-year old herdsman — and initial tests show that the herdsman’s dead dog was the likely origin of the outbreak
-
-
Novartis starts human testing of swine flu vaccine
The Swiss company began testing its swine flu vaccine in 6,000 people of all ages in Britain, Germany, and the United States; the vaccine will likely be on the market before the trial finishes
-
-
Swine flu deaths reach to 1,154
Laboratory confirmed cases world-wide have reached 162,380; WHO has estimated that 2 billion people, or one in three of the world’s population, will have been infected by the virus by the end of the pandemic
-
-
DHS is searching for buyers for Plum Island facility
The Plum Island Biosafety level 4 facility — the only type of research lab authorized to handle diseases that are communicable between humans and animals and for which there is no known cure — is aging; DHS has selected a Kansas site for a new, $500 million replacement; DHS is beginning to look for buyers for the Plum Island facility
-
-
Anthrax attack on a U.S. metropolitan area could affect more than 1 million
No matter how well-organized and prolonged a treatment program is, it must be quickly implemented; a campaign of powerful antibiotics initiated two days after exposure would protect as many as 87 percent of exposed individuals from illness
-
-
Chinese city sealed off after outbreak of bubonic plaque
Pneumonic plague, a virulent variant of the bubonic plaque, has killed two and infected 10 in a Chinese city; authorities have sealed off the city
-
-
Nasal vaccine developed for swine flu
Maryland-based Medimmune developed a nasal vaccine for the swine flu; so far, the U.S. government has ordered 12.8 million doses of H1N1 vaccine from Medimmune for $151 million and could order millions more doses
-
-
CDC to decide today on H1N1 vaccination priorities
CDC’s Advisory Committee on Immunization Practices meets today in an emergency session to discuss which groups should be targeted to receive the pandemic H1N1 vaccine and whether some should have priority
-
-
GAO slams choice of Kansas as location of new BioLab
In a critical report, the U.S. Government Accountability Office (GAO) says that the process by which DHS selected Kansas as the site for the $450 million BioLab was not “scientifically defensible”; GAO said DHS greatly underestimated the chance of accidental release and major contamination from such research; Tornado Alley may not be safe
-
-
Europe will fast-track swine flu vaccine
Worried about the eruption of swine flu infection during the coming winter, the European drug agency is accelerating the approval process for swine flu vaccine; critics, and even WHO, worry about the potential dangers of the accelerated approval process
-
-
Zimbabwe's crisis lower rate of HIV infection
Zimbabwe has been in an economic and social free fall for a while: a third of the population has fled the country; unemployment is at 80 percent; the inflation rate can no longer be calculated; social services have collapsed; the one positive aspect of this catastrophe: men are short of money to pay prostitutes or be sugar daddies and keep mistresses, leading to a decline in the rate of HIV infection
-
-
When will swine flu vaccine be available?
Here are clarifications to some of the confusion surrounding swine flu: pregnant women appear more susceptible to infection; WHO estimates that by August, global production of the vaccine will reach 94.5 million doses per week; pregnant women and obese people will likely be first to be vaccinated
-
-
Scientists unveil new weapon in swine flu fight
Taiwanese researchers say they have developed an organic compound which could help control the global swine flu epidemic; the compound can destroy viruses such as A(H1N1) swine flu and avian influenza
-
-
WHO: Swine flu sweeping world at "unprecedented speed"
WHO said Friday that the speed at which the swine flu epidemic is spreading could tip the world into deflation and delay the economic recovery
-
-
Judge dismisses lawsuit objecting to Kansas location of biolab
Texas Bio- and Agro-Defense Consortium sued DHS over the department’s decision to build the new BioLab Level 4 in Kansas; judge dismisses case — but without prejudice, opening the way for the consortium to refile the lawsuit later
-